• Clover Health Investments Corp CLOV.OQ reported a quarterly adjusted loss of 4 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -14 cents. The mean expectation of four analysts for the quarter was for a loss of 6 cents per share. Wall Street expected results to range from -7 cents to -6 cents per share.

• Revenue fell 34% to $336.96 million from a year ago; analysts expected $382.55 million.

• Clover Health Investments Corp's reported EPS for the quarter was a loss of 4 cents​.

• The company reported a quarterly loss of $22.09 million.

• Clover Health Investments Corp shares had risen by 31.4% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 2.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the managed healthcare peer group is also "hold"

Wall Street's median 12-month price target for Clover Health Investments Corp is $4.50

This summary was machine generated from LSEG data February 28 at 02:20 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)